Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.
作者信息
Horton D Kevin, Mehta Paul, Antao Vinicius C
机构信息
Agency for Toxic Substances and Disease Registry, Atlanta, Georgia.
出版信息
JAMA. 2014 Sep 17;312(11):1097-8. doi: 10.1001/jama.2014.9799.
Abstract
摘要
相似文献
1
Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.
JAMA. 2014 Sep 17;312(11):1097-8. doi: 10.1001/jama.2014.9799.
2
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
MMWR Surveill Summ. 2016 Aug 5;65(8):1-12. doi: 10.15585/mmwr.ss6508a1.
3
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
MMWR Suppl. 2014 Jul 25;63(7):1-14.
4
The National Registry of Veterans with amyotrophic lateral sclerosis.
Neuroepidemiology. 2008;30(3):180-90. doi: 10.1159/000126910. Epub 2008 Apr 18.
5
A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010-2018.
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Feb;25(1-2):211-213. doi: 10.1080/21678421.2023.2264922. Epub 2024 Jan 23.
6
Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.
Neuroepidemiology. 2018;51(3-4):149-157. doi: 10.1159/000488798. Epub 2018 Aug 9.
7
Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug;23(5-6):378-382. doi: 10.1080/21678421.2021.2023190. Epub 2022 Jan 13.
8
The underestimation of familial ALS and counseling patients with sporadic ALS.
Neurology. 2014 Jan 7;82(1):13-4. doi: 10.1212/01.wnl.0000438234.86588.10. Epub 2013 Dec 4.
9
National amyotrophic lateral sclerosis case registry.
JAMA. 1979 Jun 1;241(22):2379.
10
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
Am J Public Health. 2015 Jun;105(6):e7-9. doi: 10.2105/AJPH.2015.302747.
引用本文的文献
1
Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry.
Brain Sci. 2025 Jan 31;15(2):143. doi: 10.3390/brainsci15020143.
2
What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology.
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):615-624. doi: 10.1080/21678421.2024.2349920. Epub 2024 May 8.
3
Reproductive History and Age of Onset for Women Diagnosed with Amyotrophic Lateral Sclerosis: Data from the National ALS Registry: 2010-2018.
Neuroepidemiology. 2021;55(5):416-424. doi: 10.1159/000516344. Epub 2021 Jul 2.
4
Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review.
Biomed Eng Online. 2021 Jun 15;20(1):61. doi: 10.1186/s12938-021-00896-2.
5
History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010-2018.
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):535-544. doi: 10.1080/21678421.2021.1910308. Epub 2021 Apr 24.
6
Recruitment of population-based controls for ALS cases from the National ALS Registry.
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):395-400. doi: 10.1080/21678421.2021.1887262. Epub 2021 Apr 16.
7
Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.
Sci Rep. 2021 Mar 18;11(1):6207. doi: 10.1038/s41598-021-85395-z.
8
Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):413-420. doi: 10.1080/21678421.2019.1612435. Epub 2019 May 26.
9
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.
Neurology. 2019 Mar 5;92(10):469-480. doi: 10.1212/WNL.0000000000007044. Epub 2019 Feb 15.
10
The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
BMC Neurol. 2018 Aug 13;18(1):111. doi: 10.1186/s12883-018-1118-0.
本文引用的文献
1
Feasibility of creating a National ALS Registry using administrative data in the United States.
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):433-9. doi: 10.3109/21678421.2014.887119. Epub 2014 Mar 6.
2
CDC's vision for public health surveillance in the 21st century. Introduction.
MMWR Suppl. 2012 Jul 27;61(3):1-2.
3
Incidence of amyotrophic lateral sclerosis in Europe.
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90. doi: 10.1136/jnnp.2009.183525. Epub 2009 Aug 25.
Zotero 插件